WPI 2357 Pill: yellow, capsule/oblong, 16mm
The pill with imprint WPI 2357 (Yellow, Capsule/Oblong, 16mm) has been identified as Topiramate Extended-Release 50 mg and is used for Lennox-Gastaut Syndrome, Migraine Prevention, Epilepsy, Seizure Prevention, and Seizures. It belongs to the drug class carbonic anhydrase inhibitor anticonvulsants and is not a controlled substance.
Images for WPI 2357
Topiramate Extended-Release
- Imprint
- WPI 2357
- Strength
- 50 mg
- Color
- Yellow
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00480-2357
See also:
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,343)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR, Topiragen
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Oral Solution (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.